KYME PIERRE enters ARMATA PHARMACEUTICALS, INC. with 10K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 6/28/2024ACC: 0001104659-24-076423
Officer· Chief Business Officer
Since Mar 2026
10K
Baseline shares
100% direct
10K
Direct ownership
1 position
40K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned10K
Total
10K direct10K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 10K | Direct |
| Total | 10K | 10K direct |
Derivative Holdings1
Stock Options (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
40K
Shares owned
N/A
Exercise price
3.38
Expiration
—
Exercise window
—
Total
Underlying
40K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) Direct | Common Stock | 3.38 | — | — | 40K | N/A |
| Total | 40K | 0.00 | ||||